PORT-A-CATH II RDD Arterial Access System Receives 510k Clearance and CE Mark.ST. PAUL, Minn. -- Smiths Medical MD, Inc. announced that it has received FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. 510(k) Pre-market Notification clearance and CE mark for its new PORT-A-CATH(R) II RDD RDD Random Digit Dialing RDD RDF (Resource Description Framework) Declarative Description RDD Radiological Dispersal Device RDD Rights Data Dictionary RDD Radiological Dispersion Device RDD Respiratory Drug Delivery Arterial Access System for the treatment of liver cancer Liver Cancer Definition Liver cancer is a relatively rare form of cancer but has a high mortality rate. Liver cancers can be classified into two types. . The PORT-A-CATH(R) II RDD arterial access system is a site-directed arterial implantable access system designed to permit prolonged or repeated access to the arterial system for intra-arterial therapy. The system consists of a portal with a self-sealing silicone septum septum /sep·tum/ (sep´tum) pl. sep´ta [L.] a dividing wall or partition. alveolar septum interalveolar s. (accessible by percutaneous needle puncture), a single-lumen silicone catheter, a hemostasis hemostasis /he·mo·sta·sis/ (he?mo-sta´sis) (he-mos´tah-sis) 1. the arrest of bleeding by the physiological properties of vasoconstriction and coagulation or by surgical means. 2. sleeve assembly, and a 3 French micro-catheter assembly which is placed in the hepatic artery using an angiographic placement procedure. There are many therapies used to treat liver cancer, which include surgical resection, RF ablation, chemoembolization, and site-directed therapy with an implantable pump. The PORT-A-CATH(R) II RDD arterial access system is a less invasive alternative to the implantable pumps. Smiths Medical MD, Inc. is a world leader in the design, manufacture, and distribution of medical devices used in infusion therapy, including PORT-A-CATH(R), P.A.S. PORT(R), and ProPort(R) implantable access systems; GRIPPER PLUS(R) safety huber needles; TruFlow(R) dialysis and CliniCath(R) infusion catheters; CADD (Computer-Aided Design and Drafting) CAD systems with additional features for drafting, such as dimensioning and text entry. CADD - Computer Aided Detector Design: a project to develop standards and methods to allow cooperation between HEP (R) ambulatory infusion pumps; the CozMore(TM) insulin technology system; and large volume infusion pumps. Headquartered in St. Paul, Minnesota, Smiths Medical MD (Medication Delivery) is part of Smiths Group plc, London, and is committed to developing the highest quality, most reliable products to provide innovative, convenient, and cost-effective drug delivery worldwide. For more information, visit www.smiths-medical.com or call 1-800-426-2448. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion